Roivant Sciences Ltd

23.10.2023 г., 19:26 ч. UTC

Trending: Roche to Buy Telavant From Roivant and Pfizer

23.10.2023 г., 08:01 ч. UTC

Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update

23.10.2023 г., 05:35 ч. UTC

Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal

27.03.2024 г., 13:51 ч. UTC

Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck -- WSJ

27.03.2024 г., 10:16 ч. UTC

Stocks to Watch Wednesday: GameStop, Robinhood, Merck, Carnival -- WSJ

14.12.2023 г., 14:03 ч. UTC

Roche Completes Acquisition of Telavant From Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease

24.10.2023 г., 12:00 ч. UTC

This $5 Billion Biotech Home Run Took Less Than a Year -- Heard on the Street -- WSJ

23.10.2023 г., 20:05 ч. UTC

Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout -- IBD

23.10.2023 г., 15:30 ч. UTC

Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout -- IBD

23.10.2023 г., 10:55 ч. UTC

Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion -- Update

23.10.2023 г., 08:44 ч. UTC

These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet -- Barrons.com

23.10.2023 г., 08:17 ч. UTC

Roche's Acquisition Could Start to Turn Sentiment Around -- Market Talk